{"title": "Epigenetic analysis of aggressive brain tumors", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "Epigenetic analysis of aggressive brain tumors"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/08/180827110835.htm"}], "link": "https://www.sciencedaily.com/releases/2018/08/180827110835.htm", "summary": "Glioblastoma is a brain cancer with devastating prognosis. It is caused by numerous genetic defects, which make it difficult to treat. A new study demonstrates how epigenetic analysis of tumor samples collected in routine clinical practice could be used to better classify and treat the disease.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/personalized_medicine.xml", "value": "Glioblastoma is a brain cancer with devastating prognosis. It is caused by numerous genetic defects, which make it difficult to treat. A new study demonstrates how epigenetic analysis of tumor samples collected in routine clinical practice could be used to better classify and treat the disease."}, "published": "Mon, 27 Aug 2018 11:08:35 EDT", "published_parsed": [2018, 8, 27, 15, 8, 35, 0, 239, 0], "id": "https://www.sciencedaily.com/releases/2018/08/180827110835.htm", "guidislink": false}